NIH inks $5m partnership with PathMaker Neurosystems for MyoRegulator spasticity device

PathMaker Neurosystems said today it signed a $5 million cooperative partnership deal with the National Institutes of Health to support continued development of its MyoRegulator neurostimulation system designed to treat spasticity secondary to stroke. The MyoRegulator device, based on PathMaker’s DoubleStim technology, is designed to provide simultaneous, non-invasive stimulation at spinal and peripheral locations, the Boston and Paris-based company said. The money comes as part of a four-year grant awarded through the CREATE Devices program which also provides a partnership with the NIH’s National Institute of Neurological Disorders and Stroke, PathMaker said. “We are truly honored and delighted to receive this support from NINDS to advance our breakthrough non-invasive neuromodulation technology that can benefit many patients in desperate need of treatment options. This collaborative partnership and funding will support product engineering, multi-center U.S. pivotal trials and regulatory submission for MyoRegulator,” prez &CEO Dr. Nader Yaghoubi said in a press release. “The CREATE Devices program encourages the pursuit of translational and clinical studies for innovative therapeutic devices to treat neurological disorders,” NINDS program director Nick Langhals said in a prepared statement. Last February, PathMaker Neurosystems said that it won a grant from BpiFrance to support its MyoRegulator neurostim device. The pos...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Neuromodulation/Neurostimulation PathMaker Neurosystems Inc. Source Type: news

Related Links:

We describe the current state of the art of percutaneous LAAO in atrial fibrillation patients with a high hemorrhagic risk.
Source: Journal of Cardiovascular Medicine - Category: Cardiology Tags: Reviews Source Type: research
Thomas Platz, Martin Lotze
Source: Frontiers in Neurology - Category: Neurology Source Type: research
This report suggests a possible association between pituitary apoplexy and vardenafil use. In patients with preexisting pituitary adenoma, vardenafil may enhance the risk of pituitary apoplexy. Although headache is the most commonly reported side effect of vardenafil, pituitary apoplexy should be considered in the differential diagnosis of a patient with headache and ophthalmoplegia subsequent to vardenafil intake.
Source: Acta Neurochirurgica - Category: Neurosurgery Source Type: research
When people think about caregiving spouses, they often think of older adults. We only have to look at a young mother diagnosed with Multiple Sclerosis (MS), a young husband diagnosed with rheumatoid arthritis (RA), or in this case, a woman who’s healthy husband had a sudden, massive stroke, to know differently. Care partners come in all ages. Kathi Koll, author of “Kick-Ass Kinda Girl: A Memoir of Life, Love, and Caregiving” knows the drill. She and her husband, Don, lived a life of glitz and glamour, working and playing alongside friends who were celebrities and politicians. Read the ...
Source: Minding Our Elders - Category: Geriatrics Authors: Source Type: blogs
ConclusionIn this retrospective analysis of nearly 18,000 patients hospitalized for acute illnesses, 59.1% did not receive any VTE prophylaxis and only 7.1% received VTE prophylaxis in both the inpatient and outpatient continuum of care, despite significant VTE risk extending from hospitalization into the post-discharge period.FundingPortola Pharmaceuticals.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
(MedPage Today) -- Black women ages 65 to 74 show same stroke risk as black men
Source: MedPage Today Neurology - Category: Neurology Source Type: news
Ischemic stroke is a leading cause of disability and death worldwide among adults. The individual prognosis after stroke is extremely dependent on treatment decisions physicians take during the acute phase. In the last five years, several scores such as the ASTRAL, DRAGON, and THRIVE have been proposed as tools to help physicians predict the patient functional outcome after a stroke. These scores are rule-based classifiers that use features available when the patient is admitted to the emergency room. In this paper, we apply machine learning techniques to the problem of predicting the functional outcome of ischemic stroke ...
Source: IEEE/ACM Transactions on Computational Biology and Bioinformatics - Category: Bioinformatics Source Type: research
Ask EMS professionals to define “quality in EMS” and you may get a tip of the head and an answer like, “Well, I’m not sure, but I know it when I see it.” In today’s healthcare environment, demonstrating quality is crucial. Payers are increasingly linking payment to outcome and quality, and becoming less interesting in paying for services that don’t add value or are quality-based.1 Historically, EMS has struggled operationalizing quality-based metrics. EMS Compass and the new National EMS Quality Alliance are attempting to get quality measures for EMS launched, and more importantly,...
Source: JEMS Operations - Category: Emergency Medicine Authors: Tags: Exclusive Articles Operations Administration and Leadership Source Type: news
In conclusion, elucidation of different roles of subterminal HETEs in normal and disease states leads to identification of novel therapeutic targets and development of new therapeutic modalities in different disease states.
Source: Chemico Biological Interactions - Category: Biochemistry Source Type: research
HIGH blood pressure risk could be lowered by making some diet or lifestyle changes. You could lower your chances of deadly hypertension symptoms and signs by avoiding these four foods and drinks. They could raise your risk of deadly heart attacks and strokes.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
More News: Brain | Funding | Grants | National Institutes of Health (NIH) | Neurology | Partnerships | Stroke | Study